Literature DB >> 20607453

Utilities and QALYs in health economic evaluations: glossary and introduction.

Gianni Virgili1, Daniela Koleva, Livio Garattini, Rita Banzi, Gian Franco Gensini.   

Abstract

Year:  2010        PMID： 20607453     DOI： 10.1007/s11739-010-0420-7

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  11 in total

1.  Pharmacoeconomic analyses: making them transparent, making them credible.

Authors:  D Rennie; H S Luft
Journal:  JAMA       Date:  2000-04-26       Impact factor: 56.272

2.  National Institute for Clinical Excellence and its value judgments.

Authors:  Michael D Rawlins; Anthony J Culyer
Journal:  BMJ       Date:  2004-07-24

Review 3.  Growth and quality of the cost-utility literature, 1976-2001.

Authors:  Peter J Neumann; Dan Greenberg; Natalia V Olchanski; Patricia W Stone; Allison B Rosen
Journal:  Value Health       Date:  2005 Jan-Feb       Impact factor: 5.725

Review 4.  Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria.

Authors:  Silvia Evers; Mariëlle Goossens; Henrica de Vet; Maurits van Tulder; André Ament
Journal:  Int J Technol Assess Health Care       Date:  2005       Impact factor: 2.188

Review 5.  The futility of utility weighting.

Authors:  Robert L Kane
Journal:  J Clin Epidemiol       Date:  2008-12       Impact factor: 6.437

Review 6.  Incorporating considerations of resources use into grading recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Regina Kunz; Roman Jaeschke; Mark Helfand; Alessandro Liberati; Gunn E Vist; Holger J Schünemann
Journal:  BMJ       Date:  2008-05-24

7.  The use of QALY weights for QALY calculations: a review of industry submissions requesting listing on the Australian Pharmaceutical Benefits Scheme 2002-4.

Authors:  Paul A Scuffham; Jennifer A Whitty; Andrew Mitchell; Rosalie Viney
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

8.  Utilities of the EQ-5D: transferable or not?

Authors:  Saskia Knies; Silvia M A A Evers; Math J J M Candel; Johan L Severens; André J H A Ament
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

9.  Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.

Authors:  M F Drummond; T O Jefferson
Journal:  BMJ       Date:  1996-08-03

10.  The impact of anchor point on utilities for 5 common ophthalmic diseases.

Authors:  Bryan S Lee; Steven M Kymes; Robert F Nease; Walton Sumner; Carla J Siegfried; Mae O Gordon
Journal:  Ophthalmology       Date:  2007-09-12       Impact factor: 12.079
View more
  3 in total

Review 1.  Hand Surgery in Cambodia.

Authors:  Vaikunthan Rajaratnam; Norana Abdul Rahman; Yong-June Kim; Wee Leon Lam; James Gollogly
Journal:  J Hand Microsurg       Date:  2020-12-31

2.  Cost-Effectiveness of Population Screening Programs for Cardiovascular Diseases and Diabetes in Low- and Middle-Income Countries: A Systematic Review.

Authors:  Manushi Sharma; Renu John; Sadia Afrin; Xinyi Zhang; Tengyi Wang; Maoyi Tian; Kirti Sundar Sahu; Robert Mash; Devarsetty Praveen; K M Saif-Ur-Rahman
Journal:  Front Public Health       Date:  2022-03-08

3.  Are We Agreed? Self- Versus Proxy-Reporting of Paediatric Health-Related Quality of Life (HRQoL) Using Generic Preference-Based Measures: A Systematic Review and Meta-Analysis.

Authors:  Diana Khanna; Jyoti Khadka; Christine Mpundu-Kaambwa; Kiri Lay; Remo Russo; Julie Ratcliffe
Journal:  Pharmacoeconomics       Date:  2022-08-23       Impact factor: 4.558
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.